VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 464 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2014. The put-call ratio across all filers is 1.12 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,187,000 | +92.7% | 6,652 | +139.7% | 0.49% | +111.7% |
| Q2 2015 | $616,000 | +11.8% | 2,775 | 0.0% | 0.23% | +13.9% |
| Q1 2015 | $551,000 | +38.8% | 2,775 | 0.0% | 0.20% | +36.5% |
| Q4 2014 | $397,000 | +6.1% | 2,775 | -2.6% | 0.15% | +5.0% |
| Q3 2014 | $374,000 | -4.3% | 2,850 | -8.1% | 0.14% | -7.8% |
| Q2 2014 | $391,000 | -99.9% | 3,100 | -8.6% | 0.15% | -19.0% |
| Q1 2014 | $446,904,000 | +39240.1% | 3,390 | -65.0% | 0.19% | -60.5% |
| Q4 2013 | $1,136,000 | – | 9,675 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |